Walleye Trading’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,400
Closed -$47.1K 4239
2024
Q2
$47.1K Sell
2,400
-5,800
-71% -$121K ﹤0.01% 3611
2024
Q1
$178K Buy
8,200
+3,200
+64% +$79.5K ﹤0.01% 3487
2023
Q4
$145K Sell
5,000
-62,000
-93% -$1.66M ﹤0.01% 3967
2023
Q3
$1.79M Buy
67,000
+62,600
+1,423% +$2.14M ﹤0.01% 1867
2023
Q2
$163K Sell
4,400
-3,500
-44% -$122K ﹤0.01% 3532
2023
Q1
$247K Buy
+7,900
New +$254K ﹤0.01% 3359
2022
Q4
Sell
-16,000
Closed -$610K 5092
2022
Q3
$610K Buy
16,000
+15,900
+15,900% +$797K ﹤0.01% 2711
2022
Q2
$5K Sell
100
-10,200
-99% -$561K ﹤0.01% 4774
2022
Q1
$643K Buy
10,300
+7,100
+222% +$467K ﹤0.01% 2647
2021
Q4
$322K Buy
3,200
+2,600
+433% +$229K ﹤0.01% 3425
2021
Q3
$54K Sell
600
-2,200
-79% -$200K ﹤0.01% 4614
2021
Q2
$258K Sell
2,800
-3,100
-53% -$248K ﹤0.01% 3665
2021
Q1
$570K Sell
5,900
-5,900
-50% -$609K ﹤0.01% 2509
2020
Q4
$615K Buy
+11,800
New +$493K ﹤0.01% 2475

Other funds holding FLGT

Walleye Trading's FLGT Position: Q3 2024 in Review

Walleye Trading sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 4,604 shares — an estimated $90.3K sold.

Walleye Trading first reported a position in FLGT in Q4 2020 and held it in 8 quarters. The position peaked at $353K in Q1 2021. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Walleye Trading reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 4,604 Fulgent Genetics shares in Q3 2024, an estimated $90.3K.
  • Walleye Trading first reported a position in Fulgent Genetics in Q4 2020 and held it in 8 quarters.
  • Walleye Trading's Fulgent Genetics position peaked at $353K in Q1 2021.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.